The Mosaic Company
MOS
$22.39
+2.75%
The Mosaic Company is a leading global producer and marketer of concentrated phosphate and potash crop nutrients, operating within the Agricultural Inputs industry. As one of the world's largest integrated producers, its distinct competitive identity stems from its vertical integration, owning phosphate rock mines in the U.S. and potash mines in Canada, complemented by a major fertilizer distribution network in Brazil. The current investor narrative is dominated by a volatile commodity cycle and geopolitical supply shocks, with recent attention focused on the potential for margin expansion for North American producers like Mosaic following the reported closure of the Strait of Hormuz, which has disrupted global fertilizer supply chains.…
MOS
The Mosaic Company
$22.39
Investment Opinion: Should I buy MOS Today?
Rating: Hold. The core thesis is that MOS is a deeply cyclical stock caught in a downtrend, where the attractive valuation is offset by deteriorating fundamentals and negative momentum, making premature entry risky.
The recommendation is supported by a forward P/E of 9.50x, which prices in a recovery but remains vulnerable to estimate cuts, and a Price-to-Book of 0.63, indicating asset value support. However, opposing this are clear red flags: revenue declined -7.55% YoY in Q4, gross margins are compressing sequentially (14.17% in Q4 vs. 15.99% in Q3), and free cash flow is deeply negative at -$535M TTM. The stock also trades just 18% above its 52-week low, confirming severe technical weakness.
The two biggest risks are 1) a further decline in fertilizer prices extending the cash burn, and 2) a break below the $22.74 support triggering accelerated technical selling. This Hold would upgrade to a Buy if the stock establishes a base above $22.74 alongside evidence of margin stabilization and positive quarterly operating cash flow. It would downgrade to a Sell on a confirmed breakdown below $22.74 coupled with another quarter of sequential margin compression. Relative to its history and battered sector peers, the stock is fairly valued for the current depressed point in the cycle, but not yet undervalued enough to discount the visible near-term risks.
Sign up to view all
MOS 12-Month Price Forecast
MOS presents a classic value vs. momentum conflict. The valuation is undemanding (P/B 0.63, Forward P/E 9.5x), suggesting much bad news is priced in. However, the fundamental momentum is decisively negative, with falling revenue, compressing margins, and negative cash flow. The recent geopolitical news is a potential catalyst, but it does not directly address the core issue of cash generation. The stance is neutral, as the stock requires evidence of fundamental stabilization before the valuation can act as a effective floor. We would upgrade to bullish on confirmation of margin stabilization and a return to positive operating cash flow. We would downgrade to bearish on a break below $22.74 support alongside another quarter of deteriorating profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $29.11 and implied upside of +30.0% versus the current price.
Average Target
$29.11
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$18 - $29
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, and the available data does not include a consensus price target or recommendation breakdown, indicating insufficient coverage for a robust consensus view. This limited coverage is typical for a cyclical commodity stock and can lead to higher volatility and less efficient price discovery due to lower institutional scrutiny. Without explicit price targets, the implied signal strength cannot be quantified, but the recent institutional rating actions provide directional insight. Notably, there have been several downgrades in early 2026, including B of A Securities moving from Buy to Neutral and Barclays from Overweight to Equal Weight, reflecting a shift to a more cautious stance post-Q4 earnings. The wide range in revenue estimates for the forward period, from $10.67 billion to $13.44 billion, underscores the high uncertainty surrounding the company's near-term fundamentals, driven by volatile fertilizer prices and unpredictable global trade flows.
Bulls vs Bears: MOS Investment Factors
The evidence currently favors the bear case, as concrete financial deterioration (negative cash flow, margin compression) and a powerful technical downtrend outweigh the potential of a deeply discounted valuation. The most important tension in the investment debate is the timing and sustainability of a cyclical rebound in fertilizer prices. Bulls point to the low forward P/E of 9.5x and a geopolitical supply shock as catalysts for a sharp recovery. Bears counter that the persistent negative cash flow and sequential margin decline signal a deeper, more prolonged downcycle that the current valuation may not fully reflect. The resolution of this tension—whether Q1 2026 results show stabilization or further decline—will dictate the stock's direction.
Bullish
- Deeply Discounted Valuation Multiples: The stock trades at a trailing P/E of 14.14x and a forward P/E of 9.50x, implying a significant earnings rebound. Its Price-to-Sales (0.63) and Price-to-Book (0.63) ratios are at historical lows, suggesting the market has priced in a severe downcycle, offering a potential value entry point.
- Analyst EPS Expectations Signal Recovery: Analysts forecast a forward EPS of $2.04, which, if achieved, would represent a substantial recovery from the recent quarterly EPS of $0.55. The forward P/E of 9.50x based on this estimate indicates the market is not yet pricing in a full cyclical rebound.
- Geopolitical Supply Shock Catalyst: Recent news highlights the closure of the Strait of Hormuz, which has stranded a third of global fertilizer supply. This creates a potential margin expansion opportunity for North American producers like Mosaic with local inputs, acting as a near-term positive catalyst.
- Strong Balance Sheet Liquidity: The company maintains a current ratio of 1.32 and a moderate debt-to-equity ratio of 0.44. This provides a financial cushion to weather the current downturn in the commodity cycle without immediate solvency concerns.
Bearish
- Severe Fundamental Deterioration: Q4 2025 revenue declined 7.55% YoY to $2.60B, while gross margin compressed sequentially to 14.17% from 15.99% in Q3. This demonstrates acute pressure from falling fertilizer prices and weakening demand, challenging the core business model.
- Persistent Negative Free Cash Flow: Trailing twelve-month free cash flow is deeply negative at -$535 million, and the latest quarterly operating cash flow was -$56 million. This cash burn increases reliance on external financing during the downcycle, eroding financial flexibility.
- Technical Downtrend with No Reversal: The stock is down 24% over the past year and trades just 18% above its 52-week low of $22.74. It has underperformed the S&P 500 by -22.75 points over the past month, indicating intense, persistent selling pressure with no technical support for a near-term bounce.
- Analyst Downgrades & High Uncertainty: Recent institutional actions include downgrades from B of A Securities (Buy to Neutral) and Barclays (Overweight to Equal Weight). Furthermore, forward revenue estimates range widely from $10.67B to $13.44B, reflecting extreme uncertainty about the timing and magnitude of a recovery.
MOS Technical Analysis
The stock is in a pronounced downtrend, having declined 24.02% over the past year and currently trading at $23.15, which is just 18% above its 52-week low of $22.74 and 39% below its 52-week high of $38.23. This positioning deep in the lower end of its annual range suggests the stock is in a state of severe technical weakness, presenting a potential value trap rather than a clear opportunity, as it continues to test multi-year lows. Recent momentum is decisively negative and accelerating the longer-term downtrend, with the stock down 12.77% over the past month and 15.82% over the past three months, starkly underperforming the S&P 500 which gained 9.98% and 4.14% over the same periods, respectively. This severe underperformance, evidenced by a -22.75 relative strength figure over one month, indicates intense selling pressure with no signs of a near-term reversal. Key technical levels are clearly defined, with immediate support at the 52-week low of $22.74 and major resistance at the 52-week high of $38.23. A breakdown below $22.74 would signal a continuation of the bearish trend, while any recovery would face significant overhead supply. With a beta of 0.962, the stock's volatility is roughly in line with the broader market, but its persistent downtrend and 39.09% maximum drawdown highlight its idiosyncratic, cyclical risk profile distinct from general market movements.
Beta
0.80
0.80x market volatility
Max Drawdown
-42.4%
Largest decline past year
52-Week Range
$21-$38
Price range past year
Annual Return
-32.0%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | -9.6% | +8.6% |
| 3m | -28.1% | +6.7% |
| 6m | -12.4% | +9.8% |
| 1y | -32.0% | +26.6% |
| ytd | -10.5% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Revenue is under significant pressure, with the most recent Q4 2025 figure of $2.60 billion representing a 7.55% year-over-year decline, continuing a decelerating trend from stronger growth in prior quarters of 2025. Segment data shows the Phosphates segment contributed $1.01 billion and Potash $681 million in the latest period, but the overall trajectory implies weakening fertilizer pricing and demand, which challenges the core investment thesis tied to the agricultural cycle. Profitability has deteriorated sharply, with Q4 2025 net income at $162 million (a 6.23% net margin) and gross margin compressing to 14.17%, down from 15.99% in Q3 2025 and 18.63% in Q1 2025. This margin compression, against a trailing twelve-month net margin of 4.49%, indicates the company's earnings are highly sensitive to falling commodity prices, moving it away from the peak profitability seen in early 2025. The balance sheet and cash flow position is concerning, with a debt-to-equity ratio of 0.44 indicating moderate leverage, but free cash flow for the trailing twelve months is deeply negative at -$535 million, and the latest quarterly operating cash flow was -$56 million. With an ROE of 4.47% and a current ratio of 1.32, the company maintains adequate liquidity but is not generating sufficient internal cash to fund operations comfortably, increasing its reliance on external financing or drawing down liquidity during this downcycle.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$-534600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 14.14x, while the forward P/E is significantly lower at 9.50x, based on an estimated EPS of $2.04. This substantial gap implies the market expects a meaningful earnings recovery in the coming year, pricing in a cyclical rebound from currently depressed levels. Compared to sector averages, Mosaic trades at a deep discount on a Price-to-Sales basis, with a PS ratio of 0.63, and on a Price-to-Book basis, with a PB ratio of 0.63. The EV/EBITDA of 4.84 is also low, suggesting the market is assigning a bargain-basement multiple reflective of the downturn in the fertilizer cycle and perceived near-term earnings risk. Historically, the current trailing P/E of 14.14x sits well below the stock's own historical range observed in recent years, where P/E ratios have fluctuated wildly from negative figures during losses to as high as 57.77x in early 2024. The current PB ratio of 0.63 is near the bottom of its historical band, which has ranged from approximately 0.59 to over 2.09. This positioning at historical lows suggests the market is pricing in significant fundamental deterioration or a prolonged downcycle, offering a value proposition but also reflecting deep-seated pessimism.
PE
14.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -702x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on cash burn and margin volatility. The company's trailing FCF of -$535M and negative quarterly operating cash flow indicate it is not self-funding during the downturn, increasing reliance on its balance sheet. Profitability is highly sensitive to commodity prices, as evidenced by the gross margin compression from 18.63% in Q1 2025 to 14.17% in Q4 2025. With a net margin of just 4.49% TTM, even minor price declines can push earnings toward breakeven, jeopardizing the dividend (payout ratio of 52%).
Market & Competitive Risks stem from its pure-play cyclicality and valuation compression. Trading at a forward P/E of 9.5x, the stock is cheap but may not be a value trap if the cycle trough is longer than expected. The stock's beta of 0.96 suggests market-correlated moves, but its -39% drawdown and severe underperformance (-53 pts vs SPY over 1 year) highlight idiosyncratic, commodity-driven risk. The recent geopolitical news is a double-edged sword; while it may boost North American margins, prolonged trade disruption could also depress global agricultural demand, offsetting benefits.
Worst-Case Scenario involves a continuation of the current downtrend exacerbated by a global demand slowdown. A sequence of further quarterly earnings misses, a dividend cut due to sustained negative FCF, and analyst target reductions could trigger a re-test and break of the 52-week low at $22.74. Given the stock's proximity to this level, a breakdown could catalyze a swift decline toward the $20 support zone, representing a potential loss of approximately -14% from the current price of $23.15. In an extended bear case where fertilizer prices remain depressed for multiple quarters, the stock could challenge the $18-$20 range, implying a downside of -22% to -30%.
FAQ
The key risks are, in order of severity: 1) Commodity Price Risk: Earnings and cash flow are directly tied to volatile phosphate and potash prices, which are currently in decline (evidenced by falling gross margins). 2) Financial Risk: The company is burning cash, with -$535M in trailing FCF, threatening its dividend and financial flexibility. 3) Technical/Momentum Risk: The stock is in a powerful downtrend, down 24% over the past year and testing its 52-week low, which can become a self-fulfilling prophecy. 4) Cyclical Timing Risk: The fertilizer cycle may have a longer trough than anticipated, delaying any recovery priced into the forward P/E.
The 12-month forecast is bifurcated, with a base case target range of $25-$30 (50% probability), a bull case of $32-$38 (25% probability), and a bear case of $20-$23 (25% probability). The base case, which is most likely, assumes the cycle finds a bottom, earnings stabilize near the analyst consensus EPS of $2.04, and the stock's valuation multiples stop contracting. The key assumption is that fertilizer prices do not decline further from current levels, allowing margins to find a floor. The wide range of outcomes highlights the stock's high sensitivity to commodity prices.
MOS is fairly valued to slightly undervalued relative to its own asset base and earnings potential, but this is appropriate given the cyclical risks. The Price-to-Book ratio of 0.63 suggests the market values the company below the theoretical liquidation value of its mines and assets. The forward P/E of 9.50x is low, implying the market expects only a modest earnings recovery. Compared to historical multiples, the stock is cheap, but this discount reflects the real and present danger of a prolonged downcycle. The valuation implies the market expects subpar returns on capital and continued earnings volatility.
MOS is a high-risk, potentially high-reward investment that is not a good buy for most investors at this moment. For speculative value investors, the deep discount on valuation (P/B 0.63, Forward P/E 9.5x) is compelling. However, the severe technical downtrend, negative free cash flow of -$535M, and sequential margin compression make timing the entry exceptionally difficult. It could be a good buy for those with a long-term horizon who can average in slowly, but it is a poor choice for short-term traders or risk-averse investors awaiting clearer signs of a fundamental bottom.
MOS is strictly suitable for long-term, patient investors with a minimum horizon of 2-3 years. The stock's high beta (0.96) and exposure to volatile commodity cycles make it a poor short-term trading vehicle, as evidenced by its -39% maximum drawdown. There is no visibility on near-term catalysts to drive a sustained rally outside of unpredictable geopolitical events. A long-term horizon allows an investor to potentially benefit from the full commodity cycle upswing while ignoring the interim volatility. Income seekers should be cautious, as the 3.7% dividend yield is at risk if negative free cash flow persists.